5-azacytidine
Showing 1 - 16 of 16
Squamous Cell Carcinoma of Head and Neck Trial (Combination 5-azacytidine and nivolumab, 5-azacytidine, Nivolumab)
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- Combination 5-azacytidine and nivolumab
- +2 more
- (no location specified)
Dec 7, 2022
Leukemia Trial in Houston (Brentuximab Vedotin, 5-Azacytidine)
Terminated
- Leukemia
- Brentuximab Vedotin
- 5-Azacytidine
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 7, 2022
AML, Childhood Trial in United States (Nivolumab, 5-azacytidine)
Active, not recruiting
- AML, Childhood
- Nivolumab
- 5-azacytidine
-
Los Angeles, California
- +11 more
Oct 10, 2022
MDS, MDS/MPN Crossover Syndromes Trial in Cleveland (5-azacytidine, Decitabine)
Recruiting
- Myelodysplastic Syndromes
- MDS/MPN Crossover Syndromes
- 5-azacytidine
- Decitabine
-
Cleveland, OhioCleveland Medical Center, University Hospitals Seidman Cancer Ce
Aug 10, 2022
Leukemia, Erythroblastic, Acute, MDS Trial in New York (5-Azacytidine, Fludarabine, Melphalan)
Completed
- Leukemia, Erythroblastic, Acute
- Myelodysplastic Syndromes
- 5-Azacytidine
- +4 more
-
New York, New YorkWeill Cornell Medical College
Aug 25, 2021
MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Worldwide (Panobinostat (LBH589), 5-Azacytidine)
Completed
- Myelodysplastic Syndromes
- +2 more
- Panobinostat (LBH589)
- 5-Azacytidine
-
Augusta, Georgia
- +37 more
Jul 20, 2020
Brain Tumor Recurrent Trial in Houston (5-Azacytidine)
Completed
- Brain Tumor Recurrent
- 5-Azacytidine
-
Houston, TexasUTHealth & Children's Memorial Hermann Hospital
Nov 28, 2018
Leukemia Trial in Houston (5-azacytidine, PKC412)
Completed
- Leukemia
- 5-azacytidine
- PKC412
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 18, 2018
MDS Trial in Italy (5-Azacytidine, Valproic Acid, ATRA)
Completed
- Myelodysplastic Syndromes
- 5-Azacytidine
- +2 more
-
Arezzo, Italy
- +6 more
Aug 4, 2018
Leukemia, MDS Trial in Columbus (lintuzumab, 5-azacytidine)
Terminated
- Leukemia
- Myelodysplastic Syndromes
- lintuzumab
- 5-azacytidine
-
Columbus, OhioOhio State University Medical Center
Apr 3, 2017
Leukemia Trial in Houston (5-Azacytidine, Lenalidomide)
Completed
- Leukemia
- 5-Azacytidine
- Lenalidomide
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 19, 2016
Myelodysplastic Syndrome Trial in Richmond (5-azacytidine)
Completed
- Myelodysplastic Syndrome
- 5-azacytidine
-
Richmond, VirginiaMassey Cancer Center / Virginia Commonwealth University
Feb 3, 2016
Chronic Lymphocytic Leukemia, Leukemia Trial in Houston (5-Azacytidine)
Terminated
- Chronic Lymphocytic Leukemia
- Leukemia
- 5-Azacytidine
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 26, 2015
Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Leukemia Trial in Houston (5-Azacytidine, Ara-C, Valproic Acid (VPA))
Completed
- Acute Myelogenous Leukemia
- +2 more
- 5-Azacytidine
- +2 more
-
Houston, TexasUT MD Anderson Cancer Center
Aug 1, 2012
Beta Thalassemia Trial run by the NIDDK (5-Azacytidine)
Completed
- Beta Thalassemia
- 5-Azacytidine
-
Bethesda, MarylandNational Institute of Diabetes and Digestive and Kidney Diseases
Mar 3, 2008